UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

FDA Clears New Automated TEE Probe Disinfector

CS Medical has announced the successful clearance of a new Class II medical device by the U.S. FDA and Health Canada, TD 200 Automated TEE Probe Disinfector with TD 12 AquaCide high-level disinfectant.

“Building off the TD 100 platform, TD 200 with TD 12 AquaCide provides customers with a faster high-level disinfection time and an overall quicker total cycle time of ten minutes,” according to a release from CS Medical.

“TD 200 is the first medical device cleared in North America which provides high-level disinfection in just three minutes. The single-use biocide, TD 12 AquaCide comes in granulated form. The TD 12 AquaCide bottle is pierced inside the TD 200, is mixed with water, and heated to create a liquid high-level disinfectant. Simple step-by-step instructions are displayed on the LCD screen for the end-user,” the release adds.

“Today’s news shows CS Medical’s continued commitment to providing products and services that effectively reprocess TEE ultrasound probes. TD 12 AquaCide provides new and exciting opportunities for CS Medical. With a quicker high-level disinfection claim than TD 5 or TD 8, as well as not requiring deactivation prior to disposal, TD 12 AquaCide will reduce reprocessing time and reduce potential ecosystem damage. TD 200 with TD 12 AquaCide is the combination of years of research, development, and commitment by our entire staff,” said Mark Leath, CS Medical president. “TD 200 with TD 12 AquaCide is another example of our pledge to work with health care professionals and other professional organizations to reduce HAIs and increase awareness for a better and safer health care system. In addition to our employees, I am thankful and appreciative of the cooperation and assistance given to us by the TEE ultrasound probe manufacturers, without whom TD 200 with TD 12 AquaCide would not be the product it is today.”

For more information, visit or call 919-255-9472.



Submit a Comment

Your email address will not be published. Required fields are marked *